/PRNewswire/ The addiction therapeutics market size is forecast to grow by USD 9.86 billion between 2022 and 2027 at a CAGR of 7.65%. The growth of the.
/PRNewswire/ Mallinckrodt plc (NYSE American: MNK) ("Mallinckrodt" or the "Company"), a global specialty pharmaceutical company, today reported results for.
/PRNewswire/ Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that Siggi Olafsson, President and Chief.
/PRNewswire/ The Radiation Oncology Market by Type, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio..
/PRNewswire/ Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced that it will report fourth quarter 2022.